Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Ann Neurol. 2011 May;69(5):878-91. doi: 10.1002/ana.22299. Epub 2011 Mar 9.
The subventricular zone (SVZ) of the brain constitutes a niche for neural stem and progenitor cells that can initiate repair after central nervous system (CNS) injury. In a relapsing-remitting model of experimental autoimmune encephalomyelitis (EAE), the neural stem cells (NSCs) become activated and initiate regeneration during acute disease, but lose this ability during the chronic phases of disease. We hypothesized that chronic microglia activation contributes to the failure of the NSC repair potential in the SVZ.
Using bromodeoxyuridine injections at different time points during EAE, we quantified the number of proliferating and differentiating progenitors, and evaluated the structure of the SVZ by electron microscopy. In vivo minocycline treatment during EAE was used to address the effect of microglia inactivation on SVZ dysfunction.
In vivo treatment with minocycline, an inhibitor of microglia activation, increases stem cell proliferation in both naive and EAE animals. Minocycline treatment decreases cortical and periventricular pathology in the chronic phase of EAE, improving the proliferation of Sox2 stem cells and NG2 oligodendrocyte precursors cells originating in the SVZ and their differentiation into mature oligodendrocytes.
These data suggest that failure of repair observed during chronic EAE correlates with microglia activation and that treatments targeting chronic microglial activation have the potential for enhancing repair in the CNS.
大脑的侧脑室下区(SVZ)构成了神经干细胞和祖细胞的龛位,这些细胞可以在中枢神经系统(CNS)损伤后启动修复。在实验性自身免疫性脑脊髓炎(EAE)的复发缓解模型中,神经干细胞(NSCs)在急性疾病期间被激活并启动再生,但在疾病的慢性阶段丧失了这种能力。我们假设慢性小胶质细胞激活导致 SVZ 中的 NSC 修复潜能丧失。
通过在 EAE 期间的不同时间点注射溴脱氧尿苷,我们量化了增殖和分化祖细胞的数量,并通过电子显微镜评估了 SVZ 的结构。在 EAE 期间体内使用米诺环素治疗,以解决小胶质细胞失活对 SVZ 功能障碍的影响。
体内用米诺环素(一种小胶质细胞激活抑制剂)治疗可增加正常和 EAE 动物中的干细胞增殖。米诺环素治疗可减少 EAE 慢性期的皮质和脑室周围病变,增加起源于 SVZ 的 Sox2 干细胞和 NG2 少突胶质前体细胞的增殖,并将其分化为成熟的少突胶质细胞。
这些数据表明,在慢性 EAE 期间观察到的修复失败与小胶质细胞激活有关,靶向慢性小胶质细胞激活的治疗方法有可能增强 CNS 中的修复。